Rates of Dysphagia-Related Diagnoses in Long-Term Survivors of Head and Neck Cancers

Otolaryngol Head Neck Surg. 2019 Oct;161(4):643-651. doi: 10.1177/0194599819850154. Epub 2019 Jun 11.

Abstract

Objective: To estimate long-term prevalence of new dysphagia-related diagnoses in a large cohort of head and neck cancer survivors.

Study design: Retrospective cohort.

Setting: Population based.

Subjects and methods: In total, 1901 adults diagnosed with head and neck cancer between 1997 and 2012 with at least 3 years of follow-up were compared with 7796 controls matched for age, sex, and birth state. Prevalence of new dysphagia-related diagnoses and procedures and hazard ratio compared to controls were evaluated in patients 2 to 5 years and 5 years and beyond after diagnosis. Risk factors for the development of these diagnoses were analyzed.

Results: Prevalence of new diagnosis and hazard ratio compared to controls remained elevated for all diagnoses throughout the time periods investigated. The rate of aspiration pneumonia was 3.13% at 2 to 5 years, increasing to 6.75% at 5 or more years, with hazard ratios of 9.53 (95% confidence interval [CI], 5.08-17.87) and 12.57 (7.17-22.04), respectively. Rate of gastrostomy tube placement increased from 2.82% to 3.32% with hazard ratio remaining elevated from 51.51 (13.45-197.33) to 35.2 (7.81-158.72) over the same time period. The rate of any dysphagia-related diagnosis or procedure increased from 14.9% to 26% with hazard ratio remaining elevated from 3.32 (2.50-4.42) to 2.12 (1.63-2.75). Treatment with radiation therapy and age older than 65 years were associated with increased hazard ratio for dysphagia-related diagnoses.

Conclusion: Our data suggest that new dysphagia-related diagnoses continue to occur at clinically meaningful levels in long-term head and neck cancer survivors beyond 5 years after diagnosis.

Keywords: dysphagia; head and neck cancer; late effects; squamous cell carcinoma; survivorship.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Cancer Survivors / statistics & numerical data*
  • Carcinoma, Squamous Cell / complications*
  • Carcinoma, Squamous Cell / therapy
  • Case-Control Studies
  • Combined Modality Therapy
  • Deglutition Disorders / epidemiology*
  • Deglutition Disorders / etiology
  • Female
  • Follow-Up Studies
  • Head and Neck Neoplasms / complications*
  • Head and Neck Neoplasms / therapy
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Retrospective Studies
  • Risk Factors